1 | SVEP1 as a Genetic Modifier of TEK-Related Primary Congenital Glaucoma. (Young TL, Whisenhunt KN, Jin J, LaMartina SM, Martin SM, Souma T, Limviphuvadh V, Suri F, Souzeau E, Zhang X, Dan Y, Anagnos E, Carmona S, Jody NM, Stangel N, Higuchi EC, Huang SJ, Siggs OM, Simões MJ, Lawson BM, Martin JS, Elahi E, Narooie-Nejad M, Motlagh BF, Quaggin SE, Potter HD, Silva ED, Craig JE, Egas C, Maroofian R, Maurer-Stroh S, Bradfield YS, Tompson SW) Invest Ophthalmol Vis Sci 2020 Oct 01;61(12):6 24 Citations |
1 | Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer. (He H, Li W, Liyanarachchi S, Srinivas M, Wang Y, Akagi K, Wang Y, Wu D, Wang Q, Jin V, Symer DE, Shen R, Phay J, Nagy R, de la Chapelle A) Proc Natl Acad Sci U S A 2015 May 12;112(19):6128-33 68 Citations |
1 | Increased susceptibility to otitis media in a Splunc1-deficient mouse model. (Bartlett JA, Meyerholz DK, Wohlford-Lenane CL, Naumann PW, Salzman NH, McCray PB Jr) Dis Model Mech 2015 May;8(5):501-8 16 Citations |
1 | Actionable, pathogenic incidental findings in 1,000 participants' exomes. (Dorschner MO, Amendola LM, Turner EH, Robertson PD, Shirts BH, Gallego CJ, Bennett RL, Jones KL, Tokita MJ, Bennett JT, Kim JH, Rosenthal EA, Kim DS, National Heart, Lung, and Blood Institute Grand Opportunity Exome Sequencing Project, Tabor HK, Bamshad MJ, Motulsky AG, Scott CR, Pritchard CC, Walsh T, Burke W, Raskind WH, Byers P, Hisama FM, Nickerson DA, Jarvik GP) Am J Hum Genet 2013 Oct 03;93(4):631-40 305 Citations |
1 | Ultra-rare mutation in long-range enhancer predisposes to thyroid carcinoma with high penetrance. (He H, Li W, Wu D, Nagy R, Liyanarachchi S, Akagi K, Jendrzejewski J, Jiao H, Hoag K, Wen B, Srinivas M, Waidyaratne G, Wang R, Wojcicka A, Lattimer IR, Stachlewska E, Czetwertynska M, Dlugosinska J, Gierlikowski W, Ploski R, Krawczyk M, Jazdzewski K, Kere J, Symer DE, Jin V, Wang Q, de la Chapelle A) PLoS One 2013;8(5):e61920 36 Citations |
1 | Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis. (Li N, Dong J, Hu Z, Shen H, Dai M) Breast Cancer Res Treat 2010 May;121(1):177-84 47 Citations |
1 | GATA4 sequence variants in patients with congenital heart disease. (Tomita-Mitchell A, Maslen CL, Morris CD, Garg V, Goldmuntz E) J Med Genet 2007 Dec;44(12):779-83 174 Citations |
1 | Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. (Buttin BM, Powell MA, Mutch DG, Babb SA, Huettner PC, Edmonston TB, Herzog TJ, Rader JS, Gibb RK, Whelan AJ, Goodfellow PJ) Am J Hum Genet 2004 Jun;74(6):1262-9 58 Citations |